The main events by the morning: November 20

AMD: $600 Target Appears Too Low Source link

The current section of the “Analysis” series covers Abbott India Ltd, a part of Abbott Group, USA. The company is a leading pharmaceutical company in India with leading brands like Thyronorm, Digene, Cremafin, Brufen, and Duphaston among many others. To benefit the maximum from this article, an investor should focus on the analysis process instead…

Another quarter has gone by and it is time for another update. For a change, I will reveal the numbers first. 3Q 2024 passive income:$85.223.17 This is a slight reduction, year on year, as 3Q 2023 passive income was:$85,307.78 Almost negligible difference but it is still a dip. The reason for this is the much lower…

Rio Tinto appoints iron ore boss Simon Trott as CEO Source link